{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:31:40Z","timestamp":1789907500131,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jaci.2016.01.051","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T19:42:17Z","timestamp":1462045337000},"page":"375-385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Primary Immune Deficiency Treatment Consortium (PIDTC) update"],"prefix":"10.1016","volume":"138","author":[{"given":"Linda M.","family":"Griffith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morton J.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald B.","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Puck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Shearer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri M.","family":"Burroughs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy R.","family":"Torgerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Decaluwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2016.01.051_bib1","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","article-title":"Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015","volume":"35","author":"Picard","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10875-015-0198-5","article-title":"The 2015 IUIS phenotypic classification for primary immunodeficiencies","volume":"35","author":"Bousfiha","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib3","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jaci.2008.09.045","article-title":"Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs","volume":"122","author":"Griffith","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2013.07.052","article-title":"Primary Immune Deficiency Treatment Consortium (PIDTC) report","volume":"133","author":"Griffith","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib5","unstructured":"Rare Diseases Act of 2002, Pub L No. 107-280 (2002)."},{"issue":"suppl","key":"10.1016\/j.jaci.2016.01.051_bib6","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/j.jaci.2009.07.053","article-title":"Primary immunodeficiencies","volume":"125","author":"Notarangelo","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1182\/asheducation-2014.1.475","article-title":"Eliminating SCID row: new approaches to SCID","volume":"2014","author":"Kohn","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jaci.2016.01.051_bib8","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/cid\/ciu1154","article-title":"Common severe infections in chronic granulomatous disease","volume":"60","author":"Marciano","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2016.01.051_bib9","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/cid\/ciu1155","article-title":"Severe infections in patients with chronic granulomatous disease","volume":"60","author":"Gennery","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2016.01.051_bib10","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1586\/1744666X.2015.1062366","article-title":"Current and emerging treatment options for Wiskott-Aldrich syndrome","volume":"11","author":"Worth","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s10875-014-0028-1","article-title":"USIDNET: a strategy to build a community of clinical immunologists","volume":"34","author":"Sullivan","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2016.01.051_bib13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jama.2014.9132","article-title":"Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States","volume":"312","author":"Kwan","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2016.01.051_bib14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jaci.2014.06.021","article-title":"Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency","volume":"134","author":"Dvorak","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib15","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.bbmt.2013.08.014","article-title":"Effect of weight and maturation on busulfan clearance in infants and small children undergoing hematopoietic cell transplantation","volume":"19","author":"Savic","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaci.2016.01.051_bib16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FTD.0000000000000131","article-title":"Population pharmacokinetics of busulfan in pediatric and young adult patients undergoing hematopoietic cell transplant: a model-based dosing algorithm for personalized therapy and implementation into routine clinical use","volume":"37","author":"Long-Boyle","year":"2015","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jaci.2016.01.051_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clim.2015.02.015","article-title":"Successful newborn screening for SCID in the Navajo Nation","volume":"158","author":"Kwan","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib18","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaci.2013.09.044","article-title":"Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience","volume":"133","author":"Shearer","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib19","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s10875-013-9917-y","article-title":"The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the Primary Immune Deficiency Treatment Consortium prospective study 6901","volume":"33","author":"Dvorak","year":"2013","journal-title":"J Clin Immunol"},{"issue":"suppl","key":"10.1016\/j.jaci.2016.01.051_bib20","doi-asserted-by":"crossref","first-page":"S289","DOI":"10.1016\/j.bbmt.2014.11.459","article-title":"Early hematopoietic cell transplant (HCT) outcomes of children with severe combined immunodeficiency disease (SCID): the first seventy four patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) prospective study 6901","volume":"21","author":"Heimall","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaci.2016.01.051_bib21","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1182\/blood-2010-10-312082","article-title":"Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience","volume":"117","author":"Slatter","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2016.01.051_bib22","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/bmt.2015.171","article-title":"Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases","volume":"50","author":"Slatter","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaci.2016.01.051_bib23","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.bbmt.2014.08.020","article-title":"Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial","volume":"12","author":"Burroughs","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaci.2016.01.051_bib24","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jaci.2013.01.047","article-title":"B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment?","volume":"131","author":"Haddad","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib25","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jaci.2015.04.027","article-title":"Radiation-sensitive severe combined immunodeficiency: the arguments for and against conditioning before hematopoietic cell transplantation\u2014what to do?","volume":"136","author":"Cowan","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib26","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1126\/science.1149726","article-title":"Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches","volume":"318","author":"Czechowicz","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jaci.2016.01.051_bib27","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0140-6736(09)60945-4","article-title":"Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1\/2 study","volume":"374","author":"Straathof","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2016.01.051_bib28","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1182\/blood-2014-09-599423","article-title":"Gamma-delta T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-alpha-beta+ \/ CD19+ lymphocytes","volume":"125","author":"Airoldi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2016.01.051_bib29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1182\/asheducation.V2012.1.230.3798312","article-title":"Haploidentical transplantation for hematologic malignancies: where do we stand?","volume":"2012","author":"Fuchs","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jaci.2016.01.051_bib30","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1182\/blood-2014-07-587477","article-title":"Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS","volume":"124","author":"Kanakry","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2016.01.051_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11882-016-0615-8","article-title":"Gene therapy for the treatment of primary immune deficiencies","volume":"16","author":"Kuo","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2016.01.051_bib32","doi-asserted-by":"crossref","first-page":"636","DOI":"10.5966\/sctm.2013-0206","article-title":"Concise review: lessons learned from clinical trials of gene therapy in monogenic immunodeficiency diseases","volume":"3","author":"Williams","year":"2014","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jaci.2016.01.051_bib33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMoa1000164","article-title":"Efficacy of gene therapy for X-linked severe combined immunodeficiency","volume":"363","author":"Hacein-Bey-Abina","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2016.01.051_bib34","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(04)17590-9","article-title":"Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector","volume":"364","author":"Gaspar","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2016.01.051_bib35","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1404588","article-title":"A\u00a0modified gamma-retrovirus vector for X-linked severe combined immunodeficiency","volume":"371","author":"Hacien-Bey-Abina","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2016.01.051_bib36","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2011.03.028","article-title":"Chronic granulomatous disease: overview and hematopoietic stem cell transplantation","volume":"127","author":"Kang","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib37","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood-2010-11-319376","article-title":"Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study","volume":"118","author":"Moratto","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2016.01.051_bib38","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.clim.2003.08.005","article-title":"An international study examining therapeutic options used in treatment of Wiskott-Aldrich syndrome","volume":"109","author":"Conley","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib39","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1084\/jem.20110200","article-title":"WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity","volume":"208","author":"Becker-Herman","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2016.01.051_bib40","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.4049\/jimmunol.1302961","article-title":"Adult thymic epithelium contains nonsenescent label-retaining cells","volume":"192","author":"Dumont-Lagac\u00e9","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib41","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1182\/blood-2011-02-334623","article-title":"Thymic T-cell development in allogeneic stem cell transplantation","volume":"117","author":"Krenger","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2016.01.051_bib42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.clim.2011.04.004","article-title":"Thymic microenvironment reconstitution after postnatal human thymus transplantation","volume":"140","author":"Li","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib43","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clim.2010.02.007","article-title":"Thymus transplantation","volume":"135","author":"Markert","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib44","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature09367","article-title":"Comprehensive methylome map of lineage commitment from haematopoietic progenitors","volume":"467","author":"Ji","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2016.01.051_bib45","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1101\/gad.1836009","article-title":"Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development","volume":"23","author":"Inlay","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.jaci.2016.01.051_bib46","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1182\/blood-2011-04-348912","article-title":"Identification of the earliest natural killer cell-committed progenitor in murine bone marrow","volume":"118","author":"Fathman","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2016.01.051_bib47","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/imr.12170","article-title":"Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation","volume":"259","author":"Smigiel","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2016.01.051_bib48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fimmu.2014.00333","article-title":"Organ-specific and memory Treg cells: specificity, development, function, and maintenance","volume":"5","author":"Gratz","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800267-4.00001-8","article-title":"Regulation of immunoglobulin class-switch recombination: choreography of noncoding transcription, targeted DNA deamination, and long-range DNA repair","volume":"122","author":"Matthews","year":"2014","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib50","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/ni.2732","article-title":"A DNA break- and phosphorylation-dependent positive feedback loop promotes immunoglobulin class-switch recombination","volume":"14","author":"Vuong","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib51","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.bbmt.2015.05.015","article-title":"Immunotherapy with donor T cells sensitized with overlapping pentadecapeptides for treatment of persistent cytomegalovirus infection or viremia","volume":"21","author":"Koehne","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaci.2016.01.051_bib52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcyt.2013.11.010","article-title":"The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care","volume":"16","author":"Saglio","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jaci.2016.01.051_bib53","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2014.11.029","article-title":"Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency","volume":"135","author":"Wehr","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2010-01-254417","article-title":"How I treat common variable immunodeficiency","volume":"116","author":"Cunningham-Rundles","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2016.01.051_bib55","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jaci.2009.10.022","article-title":"Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management","volume":"124","author":"Griffith","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib56","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/MPH.0b013e318168e750","article-title":"Progressive declines in neurocognitive function among survivors of hematopoietic stem cell transplantation for pediatric hematologic malignancies","volume":"30","author":"Shah","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaci.2016.01.051_bib57","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10875-008-9250-z","article-title":"Long-term neurocognitive function of pediatric patients with severe combined immune deficiency (SCID): pre- and post-hematopoietic stem cell transplant (HSCT)","volume":"29","author":"Lin","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2016.01.051_bib58","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/ACI.0000000000000006","article-title":"Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies","volume":"13","author":"Grunebaum","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674916300902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674916300902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:57:17Z","timestamp":1758790637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674916300902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0091674916300902"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2016.01.051","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Immune Deficiency Treatment Consortium (PIDTC) update","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2016.01.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}